Radiopharmaceutical Therapy – American Society for Radiation Oncology (ASTRO) – American Society for Radiation Oncology (ASTRO)
ASTRO is actively engaged in many domains to further the role of radiation oncology in radiopharmaceutical therapy.
ASTRO is actively engaged in many domains to further the role of radiation oncology in radiopharmaceutical therapy.
A recent survey by ASCO measuring postpandemic burnout among oncologists in the United States shows that professional satisfaction and work-life balance have significantly deteriorated over…
AbstractBackground. The COVID-19 pandemic has had a profound global impact on health-care systems and patient outcomes. However, the specific effects of th
The OncoAlert Newsletter is now out for June 23-29, 2023
Apple cider vinegar, a liquid made from fermenting apples, is said to have many potential health benefits. But what does research say about these claims?…
Arjun Ghosh, MBBS, MSc, PhD, FHEA, FACC, FESC, FRCP, FICOS, University College London Hospitals, London, UK, discusses cardiotoxicity following CAR T-cell therapy, an emerging area…
Acalabrutinib combination therapy elicits statistically significant improvement in progression-free survival for treatment-naive mantle cell lymphoma.
A recent prospective study examined the use of focal salvage reirradiation using external beam radiotherapy to determine its efficacy and feasibility.
This phase 1 dose-escalation trial examines whether inotuzumab ozogamicin plus dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin (EPOCH) is safe and effective for adults with…
Patients with metastatic colorectal cancer (mCRC) with RAS- or BRAF-mutant tumors do not benefit from epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) therapy. Among…